High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors

Yu Ikezono(Kurume University), Takuji Torimura(Omuta hospital), Hirohisa Yano(Kurume University), Jun Akiba(Kurume University), Tõru Nakamura, Akihiko Kawahara(Kurume University), Hideki Iwamoto, Osamu Tsuruta(Kurume University), Masayoshi Kage(Junshin Gakuen University), Mitsuhiko Abe(Kurume University), Takafumi Yoshida(Kurume University), Michio Sata(Kurume University), Hironori Koga(Kurume University)
Oncology Letters
July 20, 2015
10.3892/ol.2015.3513
Cited by 16

Related Papers

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600